share_log

NICE Analyst Ratings

NICE Analyst Ratings

NICE 分析師評級
Benzinga ·  2023/10/05 10:04
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/05/2023 33.83% Oppenheimer $250 → $225 Maintains Outperform
09/29/2023 13.01% DA Davidson → $190 Initiates Coverage On → Neutral
08/18/2023 41.57% RBC Capital → $238 Reiterates Outperform → Outperform
08/18/2023 104.02% JMP Securities → $343 Reiterates Market Outperform → Market Outperform
08/15/2023 101.05% Citigroup $278 → $338 Maintains Buy
07/26/2023 — William Blair Initiates Coverage On → Outperform
06/14/2023 104.02% JMP Securities → $343 Reiterates Market Outperform → Market Outperform
06/07/2023 41.57% RBC Capital → $238 Reiterates Outperform → Outperform
05/31/2023 45.13% Mizuho → $244 Initiates Coverage On → Buy
05/12/2023 36.81% Wedbush $250 → $230 Maintains Outperform
05/12/2023 39.78% Jefferies $260 → $235 Maintains Buy
05/10/2023 65.36% Citigroup $277 → $278 Maintains Buy
02/24/2023 64.76% Citigroup $301 → $277 Maintains Buy
01/17/2023 35.02% Piper Sandler $222 → $227 Upgrades Neutral → Overweight
11/11/2022 33.83% Morgan Stanley $215 → $225 Maintains Equal-Weight
11/11/2022 54.65% Citigroup $254 → $260 Maintains Buy
11/01/2022 51.08% Citigroup $275 → $254 Maintains Buy
10/11/2022 27.88% Morgan Stanley $235 → $215 Maintains Equal-Weight
08/25/2022 40.38% Piper Sandler → $236 Initiates Coverage On → Neutral
08/22/2022 48.7% Wedbush $220 → $250 Maintains Outperform
08/19/2022 63.57% JP Morgan $260 → $275 Maintains Overweight
08/19/2022 57.63% RBC Capital $240 → $265 Maintains Outperform
07/26/2022 68.33% Barclays $356 → $283 Maintains Overweight
07/14/2022 39.78% Morgan Stanley $260 → $235 Maintains Equal-Weight
05/13/2022 42.76% RBC Capital $365 → $240 Maintains Outperform
02/22/2022 54.65% Morgan Stanley $315 → $260 Maintains Equal-Weight
02/18/2022 90.34% Jefferies $350 → $320 Maintains Buy
12/16/2021 87.37% Morgan Stanley → $315 Downgrades Overweight → Equal-Weight
09/09/2021 104.02% JMP Securities $302 → $343 Maintains Market Outperform
08/06/2021 93.31% RBC Capital $300 → $325 Maintains Outperform
07/07/2021 78.44% RBC Capital → $300 Upgrades Sector Perform → Outperform
06/09/2021 54.65% JP Morgan → $260 Upgrades Neutral → Overweight
05/26/2021 72.5% Morgan Stanley $338 → $290 Maintains Overweight
05/14/2021 76.06% Citigroup $312 → $296 Maintains Buy
02/22/2021 101.05% Morgan Stanley $334 → $338 Maintains Overweight
02/19/2021 101.05% Morgan Stanley $334 → $338 Maintains Overweight
02/19/2021 69.52% Wedbush $275 → $285 Maintains Outperform
02/11/2021 72.5% Oppenheimer → $290 Assumes → Outperform
01/29/2021 96.29% Barclays $246 → $330 Upgrades Equal-Weight → Overweight
12/17/2020 98.67% Morgan Stanley $230 → $334 Upgrades Equal-Weight → Overweight
11/13/2020 36.81% Morgan Stanley $212 → $230 Maintains Equal-Weight
11/13/2020 72.5% Rosenblatt $265 → $290 Reiterates → Buy
11/13/2020 63.57% Wedbush $250 → $275 Maintains Outperform
11/03/2020 66.55% B of A Securities → $280 Initiates Coverage On → Buy
10/22/2020 57.63% Rosenblatt $260 → $265 Maintains Buy
08/07/2020 26.1% Morgan Stanley $156 → $212 Maintains Equal-Weight
06/26/2020 2.31% JP Morgan → $172 Downgrades Neutral → Underweight
06/18/2020 18.96% Oppenheimer $180 → $200 Maintains Outperform
05/15/2020 -7.21% Morgan Stanley $144 → $156 Maintains Equal-Weight
05/11/2020 -14.35% Morgan Stanley $133 → $144 Maintains Equal-Weight
03/25/2020 -20.89% Morgan Stanley $173 → $133 Maintains Equal-Weight
02/14/2020 2.9% Morgan Stanley $160 → $173 Maintains Equal-Weight
02/14/2020 18.96% Wedbush $185 → $200 Maintains Outperform
02/14/2020 15.99% Rosenblatt $187 → $195 Maintains Buy
02/14/2020 14.8% Citigroup $156 → $193 Maintains Neutral
01/27/2020 -3.05% JP Morgan → $163 Downgrades Overweight → Neutral
11/27/2019 1.12% Oppenheimer $166 → $170 Maintains Outperform
11/18/2019 -10.78% Morgan Stanley $140 → $150 Maintains Equal-Weight
11/15/2019 1.12% Wedbush $165 → $170 Maintains Outperform
09/04/2019 11.23% Rosenblatt → $187 Initiates Coverage On → Buy
08/09/2019 10.04% JMP Securities $164 → $185 Maintains Market Outperform
05/17/2019 -18.51% Citigroup $117 → $137 Maintains Neutral
05/17/2019 -2.45% JMP Securities $140 → $164 Maintains Market Outperform
05/17/2019 -23.86% Morgan Stanley $117 → $128 Maintains Equal-Weight
04/24/2019 -10.78% Barclays $124 → $150 Maintains Equal-Weight
04/18/2019 -10.78% JP Morgan $125 → $150 Upgrades Neutral → Overweight
04/17/2019 -25.65% DA Davidson $110 → $125 Maintains Neutral
04/17/2019 -13.75% Oppenheimer $125 → $145 Maintains Outperform
01/07/2019 -30.41% Morgan Stanley $107 → $117 Maintains Equal-Weight
10/19/2018 -22.67% Wedbush → $130 Initiates Coverage On → Outperform
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
10/05/2023 33.83% 奧本海默 $250→$225 維護 跑贏大盤
09/29/2023 13.01% 達·戴維森 →$190 開始承保 →中性
2023年08月18日 41.57% 加拿大皇家銀行資本 →$238 重申 跑贏→跑贏大盤
2023年08月18日 104.02% JMP證券 →$343 重申 市場表現優於→市場表現
2023年08月15日 101.05% 花旗集團 $278→$338 維護 買
07/26/2023 - 威廉·布萊爾 開始承保 →跑贏大盤
2023/06/14 104.02% JMP證券 →$343 重申 市場表現優於→市場表現
06/07/2023 41.57% 加拿大皇家銀行資本 →$238 重申 跑贏→跑贏大盤
2023年05月31日 45.13% 瑞穗 →$244 開始承保 →購買
2023年05月12日 36.81% 韋德布什 $250→$230 維護 跑贏大盤
2023年05月12日 39.78% 傑富瑞 $260→$235 維護 買
2023年05月10日 65.36% 花旗集團 $277→$278 維護 買
02/24/2023 64.76% 花旗集團 $301→$277 維護 買
01/17/2023 35.02% 派珀·桑德勒 $222→$227 升級 中性→超重
2022年11月11日 33.83% 摩根士丹利 $215→$225 維護 等重
2022年11月11日 54.65% 花旗集團 $254→$260 維護 買
11/01/2022 51.08% 花旗集團 $275→$254 維護 買
2022年10月11日 27.88% 摩根士丹利 $235→$215 維護 等重
2022年08月25日 40.38% 派珀·桑德勒 →$236 開始承保 →中性
2022/08/22 48.7% 韋德布什 $220→$250 維護 跑贏大盤
2022年08月19日 63.57% 摩根大通 $260→$275 維護 超重
2022年08月19日 57.63% 加拿大皇家銀行資本 $240→$265 維護 跑贏大盤
07/26/2022 68.33% 巴克萊 $356→$283 維護 超重
07/14/2022 39.78% 摩根士丹利 $260→$235 維護 等重
2022年05月13日 42.76% 加拿大皇家銀行資本 $365→$240 維護 跑贏大盤
02/22/2022 54.65% 摩根士丹利 $315→$260 維護 等重
02/18/2022 90.34% 傑富瑞 $350→$320 維護 買
12/16/2021 87.37% 摩根士丹利 →$315 評級下調 超重→等重
09/09/2021 104.02% JMP證券 $302→$343 維護 市場表現強於大盤
08/06/2021 93.31% 加拿大皇家銀行資本 $300→$325 維護 跑贏大盤
07/07/2021 78.44% 加拿大皇家銀行資本 →$300 升級 行業表現優於→
06/09/2021 54.65% 摩根大通 →$260 升級 中性→超重
2021/05/26 72.5% 摩根士丹利 $338→$290 維護 超重
2021/05/14 76.06% 花旗集團 $312→$296 維護 買
02/22/2021 101.05% 摩根士丹利 $334→$338 維護 超重
02/19/2021 101.05% 摩根士丹利 $334→$338 維護 超重
02/19/2021 69.52% 韋德布什 $275→$285 維護 跑贏大盤
02/11/2021 72.5% 奧本海默 →$290 假設 →跑贏大盤
2021/01/29 96.29% 巴克萊 $246→$330 升級 等重→超重
12/17/2020 98.67% 摩根士丹利 $230→$334 升級 等重→超重
11/13/2020 36.81% 摩根士丹利 $212→$230 維護 等重
11/13/2020 72.5% 羅森布拉特 $265→$290 重申 →購買
11/13/2020 63.57% 韋德布什 $250→$275 維護 跑贏大盤
11/03/2020 66.55% B of A證券 →$280 開始承保 →購買
10/22/2020 57.63% 羅森布拉特 $260→$265 維護 買
08/07/2020 26.1% 摩根士丹利 $156→$212 維護 等重
06/26/2020 2.31% 摩根大通 →$172 評級下調 中性→減持
06/18/2020 18.96% 奧本海默 $180→$200 維護 跑贏大盤
2020/05/15 -7.21% 摩根士丹利 $144→$156 維護 等重
05/11/2020 -14.35% 摩根士丹利 $133→$144 維護 等重
03/25/2020 -20.89% 摩根士丹利 $173→$133 維護 等重
02/14/2020 2.9% 摩根士丹利 $160→$173 維護 等重
02/14/2020 18.96% 韋德布什 $185→$200 維護 跑贏大盤
02/14/2020 15.99% 羅森布拉特 $187→$195 維護 買
02/14/2020 14.8% 花旗集團 $156→$193 維護 中性
2020/01/27 -3.05% 摩根大通 →$163 評級下調 超重→中性
2019年11月27日 1.12% 奧本海默 $166→$170 維護 跑贏大盤
2019年11月18日 -10.78% 摩根士丹利 $140→$150 維護 等重
2019年11月15日 1.12% 韋德布什 $165→$170 維護 跑贏大盤
2019年09月04日 11.23% 羅森布拉特 →$187 開始承保 →購買
2019年08月09日 10.04% JMP證券 $164→$185 維護 市場表現強於大盤
2019年05月17日 -18.51% 花旗集團 $117→$137 維護 中性
2019年05月17日 -2.45% JMP證券 $140→$164 維護 市場表現強於大盤
2019年05月17日 -23.86% 摩根士丹利 $117→$128 維護 等重
2019年04月24日 -10.78% 巴克萊 $124→$150 維護 等重
2019/04/18 -10.78% 摩根大通 $125→$150 升級 中性→超重
2019/04/17 -25.65% 達·戴維森 $110→$125 維護 中性
2019/04/17 -13.75% 奧本海默 $125→$145 維護 跑贏大盤
2019年07月01日 -30.41% 摩根士丹利 $107→$117 維護 等重
2018年10月19日 -22.67% 韋德布什 →$130 開始承保 →跑贏大盤

What is the target price for NICE (NICE)?

尼斯(NICE)的目標價格是多少？

The latest price target for NICE (NASDAQ: NICE) was reported by Oppenheimer on October 5, 2023. The analyst firm set a price target for $225.00 expecting NICE to rise to within 12 months (a possible 33.83% upside). 18 analyst firms have reported ratings in the last year.

奧本海默於2023年10月5日報道了NICE(納斯達克：NICE)的最新目標價。這家分析公司將NICE的目標價定為225.00美元，預計NICE將在12個月內上漲至33.83%(可能上漲33.83%)。去年有18家分析公司公佈了評級。

What is the most recent analyst rating for NICE (NICE)?

分析師對尼斯(NICE)的最新評級是多少？

The latest analyst rating for NICE (NASDAQ: NICE) was provided by Oppenheimer, and NICE maintained their outperform rating.

分析師對NICE(納斯達克：NICE)的最新評級是由奧本海默提供的，NICE維持其表現優於大盤的評級。

When is the next analyst rating going to be posted or updated for NICE (NICE)?

NICE(NICE)的下一次分析師評級將於何時發佈或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NICE, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NICE was filed on October 5, 2023 so you should expect the next rating to be made available sometime around October 5, 2024.

分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與NICE的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。NICE的上一次評級是在2023年10月5日提交的，所以你應該預計下一次評級將在2024年10月5日左右的某個時候公佈。

Is the Analyst Rating NICE (NICE) correct?

分析師的評級是不是很好？

While ratings are subjective and will change, the latest NICE (NICE) rating was a maintained with a price target of $250.00 to $225.00. The current price NICE (NICE) is trading at is $168.12, which is out of the analyst's predicted range.

雖然評級是主觀的，會發生變化，但最新的NICE(NICE)評級維持不變，目標價在250.00美元至225.00美元之間。目前尼斯(NICE)的交易價格為168.12美元，超出了分析師的預測區間。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論